📊 BZYR Key Takeaways
Investment Thesis
Burzynski Research Institute is in critical financial distress with zero revenue, massive operating losses, severely depleted assets ($2.3K), and negative stockholders equity of -$67.3K. The company is technically insolvent with liabilities exceeding assets by $67.3K and insufficient cash ($2.2K) to support ongoing operations, making recovery highly unlikely.
BZYR Strengths
- No strengths identified
BZYR Risks
- Zero revenue generation - complete loss of business operations
- Negative stockholders equity of -$67.3K indicates technical insolvency
- Massive liquidity crisis with current ratio of 0.05x and only $2.2K in cash
- Operating and free cash flows deeply negative at -$967.2K
- Total liabilities ($69.6K) far exceed total assets ($2.3K) by 30x
- Extreme negative ROA of -43893.2% indicates severe asset impairment
- No insider buying activity suggests loss of management confidence
- Inadequate working capital to support basic operations or debt service
Key Metrics to Watch
- Revenue generation or return to operations
- Stockholders equity - path to positive equity
- Cash position and sources of funding for operations
BZYR Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BZYR Profitability Ratios
BZYR vs Default Sector
How BURZYNSKI RESEARCH INSTITUTE INC compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BZYR Balance Sheet & Liquidity
BZYR 5-Year Financial Trend
5-Year Trend Summary: BURZYNSKI RESEARCH INSTITUTE INC's revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
BZYR Growth Metrics (YoY)
BZYR Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | N/A | -$328.9K | $0.00 |
| Q2 2026 | N/A | -$331.5K | $0.00 |
| Q3 2025 | N/A | -$252.1K | $0.00 |
| Q2 2025 | N/A | -$252.1K | $0.00 |
| Q1 2025 | N/A | -$331.5K | $0.00 |
| Q3 2024 | N/A | -$215.9K | $0.00 |
| Q2 2024 | N/A | -$215.9K | $0.00 |
| Q1 2024 | N/A | -$231.7K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BZYR Capital Allocation
BZYR SEC Filings
Access official SEC EDGAR filings for BURZYNSKI RESEARCH INSTITUTE INC (CIK: 0000724445)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BZYR
What is the AI rating for BZYR?
BURZYNSKI RESEARCH INSTITUTE INC (BZYR) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BZYR's key strengths?
.
What are the risks of investing in BZYR?
Zero revenue generation - complete loss of business operations. Negative stockholders equity of -$67.3K indicates technical insolvency.
What is BZYR's revenue and growth?
BURZYNSKI RESEARCH INSTITUTE INC reported revenue of $0.0.
Does BZYR pay dividends?
BURZYNSKI RESEARCH INSTITUTE INC does not currently pay dividends.
Where can I find BZYR SEC filings?
Official SEC filings for BURZYNSKI RESEARCH INSTITUTE INC (CIK: 0000724445) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BZYR's EPS?
BURZYNSKI RESEARCH INSTITUTE INC has a diluted EPS of $-0.01.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.